Physiologically based pharmacokinetic modeling of diazepam: quantitative assessment of hepatic impairment and model-informed dose optimization in patients with liver cirrhosis.

Jang YJ, Lee CH, Jang JH, Jeong SH

Open source

DOI
10.1007/s00210-026-05925-2
Published
2026 Sep 22
Container
Naunyn-Schmiedeberg's archives of pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05925-2,
  title = {Physiologically based pharmacokinetic modeling of diazepam: quantitative assessment of hepatic impairment and model-informed dose optimization in patients with liver cirrhosis.},
  author = {Jang YJ and Lee CH and Jang JH and Jeong SH},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's archives of pharmacology},
  doi = {10.1007/s00210-026-05925-2},
  url = {https://doi.org/10.1007/s00210-026-05925-2}
}

RIS

TY  - JOUR
TI  - Physiologically based pharmacokinetic modeling of diazepam: quantitative assessment of hepatic impairment and model-informed dose optimization in patients with liver cirrhosis.
AU  - Jang YJ
AU  - Lee CH
AU  - Jang JH
AU  - Jeong SH
PY  - 2026
JO  - Naunyn-Schmiedeberg's archives of pharmacology
DO  - 10.1007/s00210-026-05925-2
UR  - https://doi.org/10.1007/s00210-026-05925-2
ER  - 

APA

YJ, J., CH, L., JH, J., & SH, J. (2026). Physiologically based pharmacokinetic modeling of diazepam: quantitative assessment of hepatic impairment and model-informed dose optimization in patients with liver cirrhosis.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05925-2

Source records